Cargando…
Distinct gene mutation profiles among multiple and single primary lung adenocarcinoma
With the development of technologies, multiple primary lung cancer (MPLC) has been detected more frequently. Although large-scale genomics studies have made significant progress, the aberrant gene mutation in MPLC is largely unclear. In this study, 141 and 44 lesions from single and multiple primary...
Autores principales: | Wang, Yadong, Wang, Guanghui, Zheng, Haotian, Liu, Jichang, Ma, Guoyuan, Huang, Gemu, Song, Qingtao, Du, Jiajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755731/ https://www.ncbi.nlm.nih.gov/pubmed/36531058 http://dx.doi.org/10.3389/fonc.2022.1014997 |
Ejemplares similares
-
SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment
por: Liu, Yong, et al.
Publicado: (2022) -
Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response
por: Zheng, Haotian, et al.
Publicado: (2023) -
Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022) -
Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022) -
The Prognostic Model and Drug Sensitivity of LKB1-Mutant Lung Adenocarcinoma Based on Immune Landscape
por: Wang, Guanghui, et al.
Publicado: (2022)